Amlodipine besilate
Amlodipine Besylate, Norvasc (amlodipine besylate) is a small molecule pharmaceutical. Amlodipine besylate was first approved as Amlodipine Besylate on 1992-07-31. It is used to treat coronary artery disease, hypertension, and variant angina pectoris in the USA. It is known to target voltage-dependent L-type calcium channel subunit alpha-1D and voltage-dependent L-type calcium channel subunit alpha-1C. Norvasc's patent is valid until 2022-11-20 (FDA).
| Trade Name | Amlodipine Besylate, Norvasc |
|---|---|
| Common Name | Amlodipine besilate |
| Indication | coronary artery disease, hypertension, variant angina pectoris |
| Drug Class | Phenylpyridine vasodilators (nifedipine type) |
